Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Myofascial decompression (MFD), also known as cupping therapy, is a physical medicine technique that uses negative pressure (suction) applied by cups placed on the skin to lift and stretch the underlying fascial connective tissues[1][2][3][4][5][6][9]. The therapy aims to release myofascial adhesions, increase local blood flow, reduce pain, improve mobility, and promote healing, often in the context of musculoskeletal pain, injury rehabilitation, and movement dysfunction[1][2][3][4][5][6][7][9]. MFD is distinct from traditional cupping by integrating principles of biomechanics and movement science, often incorporating active movement during treatment sessions. Despite its wide usage, it is not a receptor or molecular entity, but a therapeutic intervention modality.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Myofascial decompression (MFD).